TOPFUND WHERE YOUR MONEY GROWS
Home / Stocks / Bharat Parenterals Ltd.
BPLPHARMA

Bharat Parenterals Ltd. Share Price

Live price, chart and which mutual funds hold this stock

TopFund Score: 52/100 · Average See breakdown ↓
…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹1,898.0

Change

+316.3 (20.0%)

Open

₹1,578.9

Prev. Close

₹1,581.7

Day High

₹1,898.0

Day Low

₹1,570.1

Volume Analysis

Traded

35,202

Delivered

19,105

Delivery %

54.27%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Trading within 3% of its 52-week high (₹1649.0)

Weaknesses (3)

  • •Low return on equity (-2.54%)
  • •Promoter holding is falling
  • •Low operating margin (3.3%)

Opportunities (1)

  • •Strong 3-year revenue growth (16.5%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹2,335.2 ₹2,116.6 ₹2,007.3 ₹1,788.7 ₹1,679.4 ₹1,460.8 ₹1,351.5
Fibonacci ₹2,116.6 ₹1,991.34 ₹1,913.96 ₹1,788.7 ₹1,663.44 ₹1,586.06 ₹1,460.8
Camarilla ₹1,988.17 ₹1,958.12 ₹1,928.06 ₹1,788.7 ₹1,867.94 ₹1,837.89 ₹1,807.83

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

—

1 Week

+23.11%

1 Month

+24.23%

3 Months

—

6 Months

—

1 Year

—

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-9.88%

Net margin -9.29% × asset turnover 0.56x × equity multiplier 1.9x

Company Overview

Sector

Healthcare

Market Cap

₹1,077 Cr

ROE

-2.54%

Book Value

₹468.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 23 Sep 2026. Not investment advice.

TopFund Analysis

Bharat Parenterals Ltd. lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 52/100. The strongest factor is Financial Strength (91/100), while Cash Flow (19/100) is the weakest area to weigh before deciding. Notably: Trading within 3% of its 52-week high (₹1649.0); low return on equity (-2.54%); promoter holding is falling. Strong 3-year revenue growth (16.5%).

TopFund Score — Fundamentals Quality

52/100 — Average

Data confidence: 73/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

91

Growth

69

Valuation

50

Cash Flow

19

Corporate Governance

43

Momentum

87

Institutional Ownership

41

Business Quality

22

Liquidity

49

From Screener.in

  • −Stock is trading at 3.31 times its book value
  • −Company has low interest coverage ratio.
  • −Company has a low return on equity of -0.79% over last 3 years.
  • −Company might be capitalizing the interest cost

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 19 Sep 19 Sep
Shareholder Meeting / Postal Ballot-Outcome of AGM 19 Sep 19 Sep
Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Sep

Public Notice for Newspaper advertisement dated September 12, 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Aug

Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.

Intimation Under Regulation 36 Of The SEBI (LODR) Regulations, 2015. 27 Aug

33rd AGM scheduled for September 19, 2026; annual report and notice dispatched to shareholders.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 70 60 60 68 93 72 72 104 116 65 65 100 94
Expenses + 59 55 53 67 88 79 69 102 102 64 63 100 85
Operating Profit 10 4 7 1 4 -8 4 2 14 1 2 -1 9
OPM % 14.95% 7.22% 11.05% 1.47% 4.85% -10.69% 5.04% 2.14% 11.88% 1.28% 2.67% -0.52% 9.1%
Other Income + 2 3 1 3 3 4 3 2 1 4 1 4 1
Interest 1 1 1 1 3 3 3 4 4 3 3 3 2
Depreciation 2 2 2 4 9 9 9 9 9 9 8 9 9
Profit before tax 10 5 5 -1 -5 -15 -6 -8 3 -7 -8 -8 -2
Tax % 30.46% 46.48% 33.46% 88.24% 85.32% 13.92% 43.01% 13.61% 133.73% 17.65% 16.77% -2.51% 138.0%
Net Profit + 7 2 4 -3 -9 -18 -8 -9 -1 -9 -10 -8 -4
EPS in Rs 13 6 7 -1 2 -12 -2 -7 12 -10 -6 -7 1
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 124 111 137 220 228 205 212 218 261 340 345 323
Expenses + 114 105 124 191 200 179 183 198 234 337 330 313
Operating Profit 10 7 12 29 28 25 29 20 27 4 16 11
OPM % 8.0% 6.0% 9.0% 13.0% 12.0% 12.0% 14.0% 9.0% 10.0% 1.1% 4.6% 3.3%
Other Income + 5 8 7 13 11 9 7 12 5 11 10 10
Interest 1 1 1 1 1 1 1 3 4 13 13 11
Depreciation 4 6 6 6 6 6 7 6 9 35 34 34
Profit before tax 9 7 13 35 33 27 28 24 19 -34 -21 -25
Tax % 31.0% 8.0% 29.0% 39.0% 26.0% 25.0% 25.0% 33.0% 44.0% 29.0% 27.0% —
Net Profit + 6 7 9 21 24 20 21 16 11 -44 -27 -30
EPS in Rs 11 12 16 37 42 36 36 28 25 -18 -12 -22
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 3.0% 4.0% -5.0% -8.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 51 58 67 88 112 138 160 177 191 324 315
Borrowings + 19 6 9 5 1 12 18 50 158 180 146
Other Liabilities + 44 40 50 60 68 43 42 118 149 138 145
Total Liabilities 120 110 132 159 188 199 226 350 504 649 613
Fixed Assets + 35 31 34 35 33 45 41 42 211 252 255
CWIP 0 0 0 1 12 0 26 99 25 31 35
Investments 0 1 1 1 0 43 11 0 0 5 6
Other Assets + 85 79 98 121 142 111 148 209 268 360 317
Total Assets 120 110 132 159 188 199 226 350 504 649 613
Equity Capital 6 6 6 6 6 6 6 6 6 7 7

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 -2 6 20 14 24 -1 22 -5 -27 38
Cash from Investing Activity + 0 -2 -8 -9 -13 -43 -7 -78 -105 -137 9
Cash from Financing Activity + 0 -8 4 -4 -3 10 9 61 110 156 -47
Net Cash Flow 0 -11 2 7 -1 -8 2 4 1 -8 1
CFO/OP 0 -8 73 107 87 123 16 150 18 -444 305
Free Cash Flow 0 -4 -2 12 0 24 -40 -68 -108 -56 -1

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 73.84% → 67.2%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 26.15% 26.15% 26.72% 26.72% 33.98% 32.16% 32.15% 32.16% 32.16% 32.17% 31.65% 31.31%
Promoters 73.84% 73.84% 73.27% 73.27% 65.35% 67.2% 67.2% 67.19% 67.19% 67.19% 67.17% 67.2%
FII 0.0% 0.0% 0.0% 0.0% 0.08% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11% 0.11%
DII 0.01% 0.01% 0.01% 0.01% 0.57% 0.54% 0.54% 0.54% 0.54% 0.54% 1.07% 1.38%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Bharat Parenterals Ltd. (this stock) 1,077 — 3.3 -2.54%
Themis Medicare Ltd. 1,077 624.0 2.7 0.41%
Laxmi Dental Limited 1,097 31.6 4.49 14.8%
Sigachi Industries Ltd 1,125 50.0 2.16 5.78%
Lincoln Pharma Ltd 1,182 12.2 1.56 12.3%
3b Blackbio Dx Ltd. 1,207 21.7 3.72 19.8%
Shree Ganesh Remedies Ltd 946 61.2 5.8 10.8%

Which Mutual Funds Hold Bharat Parenterals Ltd.?

Frequently Asked Questions about Bharat Parenterals Ltd.

Community Sentiment

What are other investors saying about Bharat Parenterals Ltd.?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.